BAX vs MDT: fair value comparison
Baxter International Inc. and Medtronic plc · Updated 2026-10-19
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, BAX currently sits closer to the top of our ranking by discount to fair value. MDT carries the stronger quality grade.
| BAX | MDT | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $24.35 | $88.48 |
| 12-month range | $15.80–$28.35 | $73.75–$105.35 |
| Rank by discount to fair value | #40 of 108 Healthcare | #41 of 108 Healthcare |
| Quality grade | D | A |
| Leverage | High | Moderate |
| Margin trend | Contracting | Expanding |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| DCF cross-check | — | Overvalued |
| 52-week position | The upper-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: BAX fair value analysis · MDT fair value analysis